Patents Assigned to NIPD GENETICS PUBLIC COMPANY LIMITED
  • Patent number: 11879157
    Abstract: The invention provides methods for assessment of risk for genetic conditions using target-enriched multiplexed parallel analysis, for example fetal risk for genetic conditions in prenatal testing. The methods of the invention utilize Target Capture Sequences (TACS) to thereby enrich for target sequences of interest, followed by massive parallel sequencing and statistical analysis of the enriched population. The methods of the disclosure can be used to determine carrier status of inheritable genetic abnormalities associated with genetic conditions and from this information the fetal risk of inheriting the genetic condition can be determined. Kits for carrying out the methods of the invention are also provided.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: January 23, 2024
    Assignee: NIPD GENETICS PUBLIC COMPANY LIMITED
    Inventors: George Koumbaris, Marios Ioannides, Kyriakos Tsangaras, Charalambos Loizides, Michalis Nicolaou, Skevi Kyriakou, Philippos Patsalis, Elena Kypri
  • Patent number: 11649500
    Abstract: The invention provides methods for assessment of fetal DNA samples using target-enriched multiplexed parallel analysis. The methods of the invention utilize Target Capture Sequences (TACS) to thereby enrich for target sequences of interest, followed by massive parallel sequencing and statistical analysis of the enriched population. The methods can be used with fetal or embryonic DNA samples, for example for the detection of the presence of genetic abnormalities, e.g., for purposes of IVF Pre-implantation Genetic Screening (PGS) and Diagnosis (PGD). Kits for carrying out the methods of the invention are also provided.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: May 16, 2023
    Assignee: NIPD GENETICS PUBLIC COMPANY LIMITED
    Inventors: George Koumbaris, Marios Ioannides, Elena Kypri, Acilleas Achilleos, Petros Mina, Kyriakos Tsangaras, Philippos Patsalis